Massachusetts Financial Services’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $693K | Sell |
|
|||||
|
2025
Q2 | $836K | Buy |
|
|||||
|
2025
Q1 | $803K | Sell |
|
|||||
|
2024
Q4 | $857K | Sell |
|
|||||
|
2024
Q3 | $864K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $560K | Sell |
|
|||||
|
2023
Q4 | $577K | Sell |
|
|||||
|
2023
Q3 | $609K | Sell |
|
|||||
|
2023
Q2 | $965K | Sell |
|
|||||
|
2023
Q1 | $1.02M | Sell |
|
|||||
|
2022
Q4 | $1.14M | Buy |
|
|||||
|
2022
Q3 | $1.49M | Sell |
|
|||||
|
2022
Q2 | $1.66M | Buy |
|
|||||
|
2022
Q1 | $1.71M | Buy |
|
|||||
|
2021
Q4 | $2.35M | Sell |
|
|||||
|
2021
Q3 | $2.62M | Sell |
|
|||||
|
2021
Q2 | $3.33M | Buy |
|
|||||
|
2021
Q1 | $1.26M | Sell |
|
|||||
|
2020
Q4 | $1.29M | Sell |
|
|||||
|
2020
Q3 | $958K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $1.54M | Buy |
|
|||||
|
2018
Q3 | $1.25M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $218K | Buy |
|
|||||
|
2017
Q4 | $194K | Buy |
|
|||||
|
2017
Q3 | $196K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $638K | Buy |
|
|||||
|
2016
Q4 | $718K | Buy |
|